Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Neoantigen and Recall Antigen with Daclizumab in Pediatric Kidney Transplant
NCT02576145Phase 4Completed
- Sponsor
- Roche
- Start
- Apr 2003
- Primary completion
- Jan 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of daclizumab in kidney transplant rejection, sponsored by Roche. Started Apr 2003; status: completed.
02
Drugs
daclizumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02576145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576145.